Loading cancer entity…
Loading cancer entity…
Clinical trials
6,745 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,044)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00441922 | Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) | completed | Phase 3 | 166 | Hellenic Oncology Research GroupOTHER | 1 | Oct 29, 2008 | clinicaltrials |
| NCT00273494 | Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2 | unknown | Phase 3 | 406 | Rigshospitalet, DenmarkOTHER | 1 | May 22, 2008 | clinicaltrials |
| NCT00148395 | Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy. | completed | Phase 3 | 280 | Aktion Bronchialkarzinom e.V.OTHER | 1 | Apr 22, 2008 | clinicaltrials |
| NCT00176137 | Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 500 | Heidelberg UniversityOTHER | 0 | Apr 22, 2008 | clinicaltrials |
| NCT00080340 | Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer | completed | Phase 3 | 520 | TelikINDUSTRY | 8 | Jan 15, 2008 | clinicaltrials |
| NCT00252707 | Iressa 2nd Line Phase III Study in Japan | completed | Phase 3 | 484 | AstraZenecaINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00190710 | A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer | completed | Phase 3 | 242 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 14, 2007 | clinicaltrials |
| NCT00243204 | Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy | terminated | Phase 3 | 400 | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00290017 | Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy | terminated | Phase 3 | 400 | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00054795 | Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART) | completed | Phase 3 | 550 | Pharmacyclics LLC.INDUSTRY | 8 | May 8, 2007 | clinicaltrials |
| NCT00034268 | A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 21 | Jul 19, 2006 | clinicaltrials |
| NCT00268684 | Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC | unknown | Phase 3 | 381 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Feb 28, 2006 | clinicaltrials |
| NCT00265694 | Random Trial for Elderly Patients With NSCLC | unknown | Phase 3 | — | Inje UniversityOTHER | 1 | Dec 15, 2005 | clinicaltrials |
| NCT00211952 | Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients | suspended | Phase 3 | 542 | Medical University of GdanskOTHER | 1 | Sep 21, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Oct 29, 2008source: clinicaltrials